
Older women could be prone to harmful inflammation from new gene therapy treatments for incurable eye diseases, new research from the University of Bristol has found.
The study, published in Molecular Therapy, showed how age and gender affected inflammation from gene therapy treatments and could cause damage to the eye and lead to vision loss in some patients.
The study showed that older female’s immune cells in mice responded differently and had an increased risk of stress and inflammation, causing damage to the eye. While eye cells in male and female animal models were found to have similar short-term immune responses, the immune cells (microglia and T cells) reacted differently at a molecular and cellular level, according to the study.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here